Annual Net Income
-$126.87 M
-$24.63 M-24.09%
December 31, 2024
Summary
- As of March 12, 2025, URGN annual net profit is -$126.87 million, with the most recent change of -$24.63 million (-24.09%) on December 31, 2024.
- During the last 3 years, URGN annual net income has fallen by -$16.05 million (-14.49%).
- URGN annual net income is now -6436.53% below its all-time high of -$1.94 million, reached on December 31, 2016.
Performance
URGN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$37.51 M
-$13.84 M-58.46%
December 1, 2024
Summary
- As of March 12, 2025, URGN quarterly net profit is -$37.51 million, with the most recent change of -$13.84 million (-58.46%) on December 1, 2024.
- Over the past year, URGN quarterly net income has dropped by -$13.84 million (-58.46%).
- URGN quarterly net income is now -390.27% below its all-time high of $12.92 million, reached on December 31, 2016.
Performance
URGN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$126.87 M
-$11.50 M-9.96%
December 1, 2024
Summary
- As of March 12, 2025, URGN TTM net profit is -$126.87 million, with the most recent change of -$11.50 million (-9.96%) on December 1, 2024.
- Over the past year, URGN TTM net income has dropped by -$11.50 million (-9.96%).
- URGN TTM net income is now -4316.48% below its all-time high of $3.01 million, reached on September 30, 2017.
Performance
URGN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
URGN Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -24.1% | -58.5% | -10.0% |
3 y3 years | -14.5% | -31.8% | -14.5% |
5 y5 years | -20.7% | +3.8% | -20.7% |
URGN Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -24.1% | at low | -71.5% | at low | -24.1% | at low |
5 y | 5-year | -24.1% | +1.3% | -71.5% | +3.8% | -24.1% | +7.3% |
alltime | all time | -6436.5% | +1.3% | -390.3% | +3.8% | -4316.5% | +7.3% |
UroGen Pharma Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$126.87 M(+24.1%) | - | - |
Dec 2024 | - | -$37.51 M(+58.5%) | -$126.87 M(+10.0%) |
Sep 2024 | - | -$23.67 M(-29.1%) | -$115.38 M(+1.6%) |
Jun 2024 | - | -$33.40 M(+3.5%) | -$113.58 M(+8.9%) |
Mar 2024 | - | -$32.29 M(+24.1%) | -$104.32 M(+2.0%) |
Dec 2023 | -$102.24 M(-6.9%) | -$26.02 M(+18.9%) | -$102.24 M(-2.7%) |
Sep 2023 | - | -$21.88 M(-9.4%) | -$105.10 M(-3.6%) |
Jun 2023 | - | -$24.14 M(-20.1%) | -$109.05 M(-2.3%) |
Mar 2023 | - | -$30.21 M(+4.7%) | -$111.60 M(+1.7%) |
Dec 2022 | -$109.78 M(-0.9%) | -$28.87 M(+11.8%) | -$109.78 M(+0.4%) |
Sep 2022 | - | -$25.83 M(-3.2%) | -$109.37 M(-3.9%) |
Jun 2022 | - | -$26.69 M(-6.0%) | -$113.75 M(+0.4%) |
Mar 2022 | - | -$28.39 M(-0.2%) | -$113.28 M(+2.2%) |
Dec 2021 | -$110.82 M(-13.7%) | -$28.45 M(-5.8%) | -$110.82 M(-1.8%) |
Sep 2021 | - | -$30.21 M(+15.2%) | -$112.89 M(+1.3%) |
Jun 2021 | - | -$26.22 M(+1.1%) | -$111.50 M(-4.4%) |
Mar 2021 | - | -$25.93 M(-15.0%) | -$116.63 M(-9.2%) |
Dec 2020 | -$128.48 M | -$30.53 M(+5.9%) | -$128.48 M(-6.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$28.82 M(-8.1%) | -$136.93 M(+5.0%) |
Jun 2020 | - | -$31.35 M(-17.1%) | -$130.37 M(+7.3%) |
Mar 2020 | - | -$37.79 M(-3.0%) | -$121.50 M(+15.5%) |
Dec 2019 | -$105.15 M(+39.0%) | -$38.97 M(+75.1%) | -$105.15 M(+17.0%) |
Sep 2019 | - | -$22.25 M(-1.0%) | -$89.89 M(+1.9%) |
Jun 2019 | - | -$22.48 M(+4.8%) | -$88.17 M(+5.3%) |
Mar 2019 | - | -$21.44 M(-9.6%) | -$83.72 M(+10.7%) |
Dec 2018 | -$75.66 M(+278.3%) | -$23.72 M(+15.5%) | -$75.66 M(+22.0%) |
Sep 2018 | - | -$20.53 M(+13.9%) | -$62.03 M(+48.4%) |
Jun 2018 | - | -$18.03 M(+34.7%) | -$41.79 M(+39.5%) |
Mar 2018 | - | -$13.38 M(+32.7%) | -$29.96 M(+49.8%) |
Dec 2017 | -$20.00 M(+930.4%) | -$10.09 M(+3284.6%) | -$20.00 M(-764.7%) |
Sep 2017 | - | -$298.00 K(-95.2%) | $3.01 M(-164.3%) |
Jun 2017 | - | -$6.20 M(+81.4%) | -$4.68 M(+160.3%) |
Mar 2017 | - | -$3.42 M(-126.4%) | -$1.80 M(-211.1%) |
Dec 2016 | -$1.94 M(-84.7%) | $12.92 M(-261.8%) | $1.62 M(-114.3%) |
Sep 2016 | - | -$7.99 M(+140.8%) | -$11.30 M(+240.8%) |
Jun 2016 | - | -$3.32 M | -$3.32 M |
Dec 2015 | -$12.69 M | - | - |
FAQ
- What is UroGen Pharma annual net profit?
- What is the all time high annual net income for UroGen Pharma?
- What is UroGen Pharma annual net income year-on-year change?
- What is UroGen Pharma quarterly net profit?
- What is the all time high quarterly net income for UroGen Pharma?
- What is UroGen Pharma quarterly net income year-on-year change?
- What is UroGen Pharma TTM net profit?
- What is the all time high TTM net income for UroGen Pharma?
- What is UroGen Pharma TTM net income year-on-year change?
What is UroGen Pharma annual net profit?
The current annual net income of URGN is -$126.87 M
What is the all time high annual net income for UroGen Pharma?
UroGen Pharma all-time high annual net profit is -$1.94 M
What is UroGen Pharma annual net income year-on-year change?
Over the past year, URGN annual net profit has changed by -$24.63 M (-24.09%)
What is UroGen Pharma quarterly net profit?
The current quarterly net income of URGN is -$37.51 M
What is the all time high quarterly net income for UroGen Pharma?
UroGen Pharma all-time high quarterly net profit is $12.92 M
What is UroGen Pharma quarterly net income year-on-year change?
Over the past year, URGN quarterly net profit has changed by -$13.84 M (-58.46%)
What is UroGen Pharma TTM net profit?
The current TTM net income of URGN is -$126.87 M
What is the all time high TTM net income for UroGen Pharma?
UroGen Pharma all-time high TTM net profit is $3.01 M
What is UroGen Pharma TTM net income year-on-year change?
Over the past year, URGN TTM net profit has changed by -$11.50 M (-9.96%)